Gout

A Study of Dotinurad Versus Allopurinol in Participants With Gout

A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

An Innovative Chinese Herbal Formula for the Treatment of Gout

Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout

A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout

The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution Time

To Evaluate the Influence of (LUA Probiotics) on Uric Acid

Musculoskeletal Ultrasound for Differentiating Rheumatoid and Gouty Arthritis

A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)

Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia

Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)

Using Gout Buddy to Enhance Gout Management

Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)

Gout in the ED and Improving Research Participation

A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients

A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing

Tahiti-families: Polynesian Families of Gout Patients

The Remote Monitoring of Gout Feasibility Study in Primary Care